News Center_News Center_Qijian-BioPharm-hgh-somatropin-Sam-GM1

CPhI India 2019

Published：

2019-11-20

Qijian Bio-Pharmaceutical expect to meet you in Delhi India
NOVEMBER 26-28,2019,BOOTH NO. 2D04

More>>

CPhI Worldwide 2019 Frankfurt Booth 12D16

Published：

2019-10-31

More>>

Drug Establishment Registration on FDA

Published：

2019-10-08

On Monday, Oct 7, 2019, Jilin Qijian Bio-Pharmaceutical Co.,Ltd. has successfully made the drug establishment registration of HGH raw material on Food and Drug Administration( FDA ).

More>>

DMF Number assigned by FDA

Published：

2019-09-04

The Food and Drug Administration (FDA) acknowledged receipt of our Human Growwth Hormone raw powder Drug Master File(DMF), the DMF assigned number is 33745,DMF type Ⅱ.

More>>

CPhI Middle East & Africa

Published：

2019-08-30

Qijian Bio-Pharmaceutical Co., Ltd will be attending CPhI Middle East & Africa from 16 to 18 September 2019 in Abu Dhabi,UAE. Welcome to visit our booth L60

More>>

Declaration

Published：

2019-05-08

Dear customer, recently we found that some people in the name of our company website to infringe our company logo, our company name and our products.

More>>

CPhI South East Asia 2019

Published：

2019-02-25

Qijian Bio-Pharmaceutical Co., Ltd will be attending CPhI South East Asia 2019 in Bangkok Thailand from Mar. 12th to 14th, weclcome to visit our booth HA34.

More>>

Viedo

Published：

2018-10-17

More>>

Qijian Bio-Pharmaceutical Co., Ltd successfully participated in the 2015 CPHI China Exhibition

Published：

2018-09-28

Qijian Bio-Pharmaceutical Co., Ltd. participated in the 15th World Pharmaceutical Raw Materials China Exhibition held in Shanghai in June 2015. The exhibition was very successful. Many customers ……

More>>